Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Dover Corp (DOV) A Good Stock To Buy?

The equity market returns were very disappointing in the third quarter, “thanks” to the slowdown of China’s economy and the weaker-than-expected U.S. economic data. It was not entirely clear whether the broader market sell-off made U.S. equity valuations undervalued, but it definitely made them more attractive. It is worth mentioning that Russell 2000 ETF (IWM) underperformed the broad-market S&P 500 ETF by more than 14 percentage points during the period of June 25, 2015 through October 30, 2015. This clearly points to the fact that most investors, including hedge fund firms and institutional investors, heavily cut their exposure to high-potential (but seemingly riskier) small-cap stocks during the bloody third quarter. So let’s take a glance at the smart money sentiment towards Dover Corp (NYSE:DOV) and see how it was affected.

Dover Corp (NYSE:DOV) was in 25 hedge funds’ portfolios at the end of the third quarter of 2015. DOV investors should be aware of a decrease in hedge fund interest recently. There were 26 hedge funds in our database with DOV positions at the end of the previous quarter. At the end of this article we will also compare DOV to other stocks including First Republic Bank (NYSE:FRC), UDR, Inc. (NYSE:UDR), and Expeditors International of Washington (NASDAQ:EXPD) to get a better sense of its popularity.

Follow Dover Corp (NYSE:DOV)
Trade (NYSE:DOV) Now!

At the moment there are a large number of signals stock market investors have at their disposal to appraise their holdings. A couple of the most under-the-radar signals are hedge fund and insider trading moves. Our experts have shown that, historically, those who follow the top picks of the best investment managers can beat their index-focused peers by a healthy amount (see the details here).

Now, we’re going to analyze the key action regarding Dover Corp (NYSE:DOV).

How have hedgies been trading Dover Corp (NYSE:DOV)?

At the end of the third quarter, a total of 25 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -4% from the second quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were increasing their stakes considerably (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Gates Capital Management, managed by Jeffrey Gates, holds the largest position in Dover Corp (NYSE:DOV). Gates Capital Management has an $155 million position in the stock, comprising 6% of its 13F portfolio. On Gates Capital Management’s heels is Richard S. Pzena of Pzena Investment Management, with an $129.1 million position; the fund has 0.8% of its 13F portfolio invested in the stock. Remaining members of the smart money that hold long positions include Joel Greenblatt’s Gotham Asset Management, David Harding’s Winton Capital Management and Cliff Asness’s AQR Capital Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.